Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: A review

https://doi.org/10.1016/0278-5846(93)90018-NGet rights and content

Abstract

Lindefors Nils: Dopaminergic Regulation of Glutamic Acid Decarboxylase mRNA Expression and GABA Release In the Striatum: A Minireview. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 1993, 17(6): 887–903.

  • 1.

    1. The majority of neurons in the striatum (caudate-putamen, dorsal striatum; nucleus accumbens, ventral striatum) and in striatal projection regions (the pallidum, the entopeduncular nucleus and substantia nigra reticulata) use γ-aminobuturic acid (GABA) as transmitter and express glutamic acid decarboxylase (GAD; rate limiting enzyme) in the synthesis of GABA. GABA is the major inhibitory transmitter in the mammlian brain.

  • 2.

    2. GAD in brain is present as two isoenzymes, GAD65 and GAD67. GAD65 is largely present as an inactive apoenzyme, which can be induced by nerve activity, while most GAD67 is present as a pyridoxal phosphate-bound permanently active holoenzyme. Thus GAD65 and GAD67 seem to provide a dual system for the control of neuronal GABA synthesis.

  • 3.

    3. GAD mRNA expression can be visualised and quantified using in situ hybridisation, and GABA release can be quantified using in vivo microdialysis.

  • 4.

    4. Different populations of GABA neurons can be distinguished in both dorsal and ventral striatum as well as in other parts of the basal ganglia.

  • 5.

    5. Inhibition of dopaminergic transmission in the striatum by lesion of dopamine neurons or by neuroleptic treatment is followed by an increased release of GABA and increased expression of GAD67 mRNA in a subpopulation of striatal medium-sized neurons which project to the globus pallidus, and increased striatal GAD enzyme activity.

  • 6.

    6. Increased dopaminergic transmission by repeated but not single doses of amphetamine is followed by decreased striatal GABA release and decreased GAD67 mRNA expression in a subpopulation of medium-sized neurons in the striatum.

  • 7.

    7. Two populations of medium-sized GABA neurons in the striatum seem to be under tonic dopaminergic influence. The majority of these GABA neurons are under inhibitory influence, whereas a small number seem to be stimulated by dopamine.

  • 8.

    8. Specific changes in activity in subpopulations of striatal GABA neurons probably mediate the dopamine-dependent hypokinetic syndrome seen in Parkinson's disease and following neuroleptic treatment.

References (54)

  • Y. Kubota et al.

    Dopaminergic axons make directly synapses with GABAregic neurons in the rat neostriatum

    Brain Res.

    (1987)
  • N. Lindefors et al.

    Increased expression of glutamic acid decarboxylase mRNA in rat substantia nigra after an ibotenic acid lesion in the caudateputamen

    Mol. Brain Res.

    (1990)
  • N. Lindefors et al.

    Amphetamine regulation of acetylcholine and γ-aminobutyric acid in nucleus accumbens

    Neuroscience

    (1992)
  • P.L. McGeer et al.

    Evidence for glutamic acid decarboxylase-containing interneurons in the neostriatum

    Brain Res.

    (1975)
  • W.T. O'connor et al.

    Short-term dopaminergic regulation of GABA release in dopamine deafferented caudate-putamen is not directly associated with glutamic acid decarboxylase gene expression

    Neurosci. Lett.

    (1991)
  • M. Reid et al.

    Intranigral GABA and dynorphin A injections modulate striatal dopamine and GABA levels: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors

    Brain Res.

    (1990)
  • J. Segovia et al.

    Transplants of fetal substantia nigra regulate glutamic acid decarboxylase gene expression in host striatal neurons

    Mol. Brain Res.

    (1991)
  • J. Segovia et al.

    Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway

    Brain Res.

    (1990)
  • J.-J. Soghomonian et al.

    Messenger RNAs encoding glutamic acid decarboxylase are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons

    Brain Res.

    (1992)
  • Y. Tanaka et al.

    Changes in γ-buturate, glutamate, aspartate, glycine, and taurine contents in the striatum after unilateral nigrostriatal lesions in rat brain

    Exp. Neurol.

    (1986)
  • M.L. Tappaz et al.

    Distribution of glutamate decarboxylase in discrete brain nuclei

    Brain Res.

    (1976)
  • G. Balcom et al.

    Regional γ-aminobuturic acid levels in rat brain determined after microwave fixation

    J. Neurochem.

    (1975)
  • J.P. Bolam et al.

    Glutamate decarboxylase-immunoreactive structures in the rat neostriatum: a correlated light and electron microscopic study including a combination of Golgi impregnation with immunocytochemistry

    J. Comp. Neurol.

    (1985)
  • S. Brené et al.

    Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen

    Exp. Brain Res.

    (1990)
  • Brownstein M. J., Mroz E. A., Tappaz M. L. and Leeman S. E. On the origin of substance P and glutamic acid...
  • M. Chesselet et al.

    Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain

    J. Comp. Neurol.

    (1987)
  • M.G. Erlander et al.

    The structural and functional heterogeneity of glutamic acid decarboxylase: A review

    Neurochemical Res.

    (1991)
  • Cited by (78)

    • Decreased GABAergic signaling, fewer parvalbumin-, somatostatin- and calretinin-positive neurons in brain of a rat model of simulated transport stress

      2021, Research in Veterinary Science
      Citation Excerpt :

      GAD is a rate-limiting enzyme in the synthesis of GABA, GAD expression is closely related to GABAergic activity. Increased expression of GAD has been considered as a sign of GABAergic hyperactivity (Lindefors, 1993) while decreased expression is associated with reduced GABA synthesis (Mason et al., 2001). Moreover, GABAergic interneurons such as PV, SOM and CR play crucial roles in neuroprotection (Liu et al., 2004; Wu et al., 2004), learning, memory, circadian rhythm, immunity, anxiety and depression (Calza et al., 1993; Dawson and Dawson, 1996).

    • Wwox deletion leads to reduced GABA-ergic inhibitory interneuron numbers and activation of microglia and astrocytes in mouse hippocampus

      2019, Neurobiology of Disease
      Citation Excerpt :

      GAD65 and GAD67 are the principal enzymes that synthesize GABA from glutamate in the mammalian brain (Lindefors, 1993). Expression of GADs has been reported to accurately reflect levels of GABA synthesis and activity (Lindefors, 1993). For instance, selective elimination of Gad65 has been shown to elicit spontaneous seizures that results in increased mortality in Gad65 −/− mice (Kash et al., 1997).

    View all citing articles on Scopus
    View full text